Skip to main content
LobbyMap

Continental Pharma Resources

Finance & Banking · Lobbying Client

C
Influence Score
47/100
Moderate Influence
$1.9M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door

Continental Pharma Resources reported $1.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Banking, Financial Institutions, Taxation. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Federal Energy Regulatory Commission
Dept of Energy
Food & Drug Administration
Small Business Administration
Dept of Defense
Dept of Housing & Urban Development
Dept of Treasury
Federal Communications Commission
Office of Management & Budget

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarCassidy & Associates LLP
FINGOVGAM
1$102K
2020 Apr-JunCassidy & Associates LLP
GAMBANFIN+1
1$131K
2020 Jul-SepBrownstein Hyatt LLP
GOVCPT
1$73K
2020 Oct-DecAkin Gump LLP
GAM
1$102K
2021 Jan-MarK&L Gates LLP
GAMFINCPT+2
1$77K
2021 Apr-JunSquire Patton Boggs LLP
FINBAN
1$79K
2021 Jul-SepHolland & Knight LLP
GOVCPTBAN
1$78K
2021 Oct-DecBrownstein Hyatt LLP
BANCPTFIN+1
1$87K

Continental Pharma Resources Lobbying FAQ

Continental Pharma Resources has spent $1.9M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Continental Pharma Resources lobbies on 6 policy issues, including Banking, Financial Institutions, Taxation, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Continental Pharma Resources has an Influence Score of 47/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Continental Pharma Resources employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Continental Pharma Resources has contacted 9 government entities as part of their lobbying activities, including Federal Energy Regulatory Commission, Dept of Energy, Food & Drug Administration.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.